Elevated serum levels of the NLRP3 inflammasome are associated with the severity of anti-NMDAR encephalitis in children

Jiaxin Yang,Yuhang Li,Hanyu Luo,Jiannan Ma,Yaxin Zheng,Lvli Zhou,Ran Ding,Linxue Meng,Xiaofang Zhang,Yan Jiang,Xiujuan Li,Siqi Hong,Li Jiang

DOI: https://doi.org/10.1016/j.cca.2023.117587

IF: 6.314

2023-10-09

Clinica Chimica Acta

Abstract:Background Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most common autoimmune encephalitis, mainly impacting young females and children. The involvement of the Nod-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and related cytokines in pediatric individuals with this condition remains unclear. Methods We collected information from 27 children who had anti-NMDAR encephalitis and 12 individuals with non-inflammatory neurological disorders as controls. We used an enzyme-linked immunosorbent assay (ELISA) to identify NLRP3 inflammasome, interleukin (IL)-1β, and IL-18 expression in cerebrospinal fluid (CSF) and matching serum samples. The modified Rankin Scale (mRS) score was performed throughout the acute phase and at the 6-month follow-up to determine the severity of the disease. The area under the curve (AUC) of the receiver operating characteristic curve was utilized to calculate the prediction efficacy. Results When compared to controls, individuals with anti-NMDAR encephalitis had significantly increased serum expression of the NLRP3 inflammasome (p<0.001), IL-1β (p<0.05), and IL-18 (p<0.01). In the acute phase, mRS scores were correlated positively with serum levels of NLRP3 inflammasome (p=0.008), IL-1β (p=0.023), and IL-18 (p<0.001). A positive connection was also found between serum levels of NLRP3 inflammasome and IL-1β (p=0.005). Furthermore, the expression of IL-1β and IL-18 in serum correlated with the 6-month follow-up outcome. The AUC for NLRP3 inflammasome in distinguishing patients with severe neurologic impairments from those with moderate impairments was 0.808 (95% CI: 0.645–0.972). Conclusion In our investigation, children with anti-NMDAR encephalitis have more severe first clinical presentations when their serum concentrations of the NLRP3 inflammasome and related cytokines were higher. These findings provide a potential role for the NLRP3 inflammasome pathway in the pathogenesis of NMDAR encephalitis and provide a basis for targeted therapeutic interventions.

medical laboratory technology